Name | Number of supported studies | Average coverage | |
---|---|---|---|
classical monocyte | 13 studies | 22% ± 8% | |
endothelial cell | 10 studies | 26% ± 9% | |
vein endothelial cell | 7 studies | 22% ± 6% | |
fibroblast | 6 studies | 22% ± 5% | |
capillary endothelial cell | 6 studies | 20% ± 4% | |
monocyte | 5 studies | 26% ± 7% | |
conventional dendritic cell | 5 studies | 24% ± 5% | |
endothelial cell of artery | 5 studies | 21% ± 8% | |
pericyte | 5 studies | 24% ± 6% | |
dendritic cell | 4 studies | 30% ± 16% | |
non-classical monocyte | 4 studies | 23% ± 9% | |
epithelial cell | 4 studies | 34% ± 22% | |
endothelial cell of vascular tree | 4 studies | 30% ± 15% | |
plasmacytoid dendritic cell | 4 studies | 18% ± 4% | |
mast cell | 3 studies | 21% ± 5% | |
squamous epithelial cell | 3 studies | 29% ± 13% | |
myeloid cell | 3 studies | 25% ± 3% | |
ciliated cell | 3 studies | 32% ± 6% | |
macrophage | 3 studies | 20% ± 5% | |
smooth muscle cell | 3 studies | 21% ± 6% | |
luminal hormone-sensing cell of mammary gland | 3 studies | 30% ± 8% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 3 studies | 24% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 5452.07 | 245 / 245 | 99% | 63.72 | 498 / 502 |
intestine | 99% | 4659.66 | 961 / 966 | 99% | 94.61 | 524 / 527 |
uterus | 99% | 3244.39 | 169 / 170 | 99% | 115.89 | 454 / 459 |
esophagus | 98% | 4989.31 | 1415 / 1445 | 100% | 151.60 | 183 / 183 |
lung | 100% | 10182.32 | 576 / 578 | 98% | 94.23 | 1134 / 1155 |
breast | 100% | 4589.51 | 458 / 459 | 98% | 79.46 | 1096 / 1118 |
bladder | 100% | 4314.10 | 21 / 21 | 96% | 82.27 | 484 / 504 |
stomach | 97% | 3324.78 | 347 / 359 | 99% | 114.14 | 282 / 286 |
liver | 100% | 9642.78 | 226 / 226 | 95% | 60.15 | 386 / 406 |
thymus | 99% | 4783.47 | 646 / 653 | 90% | 35.17 | 547 / 605 |
ovary | 84% | 2669.59 | 151 / 180 | 99% | 116.56 | 426 / 430 |
pancreas | 86% | 2574.34 | 282 / 328 | 96% | 86.39 | 171 / 178 |
kidney | 97% | 4108.06 | 86 / 89 | 85% | 40.92 | 768 / 901 |
skin | 98% | 2866.26 | 1770 / 1809 | 82% | 35.49 | 387 / 472 |
adrenal gland | 100% | 4644.98 | 258 / 258 | 61% | 21.51 | 141 / 230 |
lymph node | 0% | 0 | 0 / 0 | 100% | 119.53 | 29 / 29 |
spleen | 100% | 7149.47 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 60.82 | 1 / 1 |
peripheral blood | 100% | 8296.67 | 925 / 929 | 0% | 0 | 0 / 0 |
adipose | 99% | 5559.03 | 1196 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 103.78 | 44 / 45 |
blood vessel | 87% | 2668.96 | 1168 / 1335 | 0% | 0 | 0 / 0 |
heart | 87% | 2417.43 | 748 / 861 | 0% | 0 | 0 / 0 |
muscle | 46% | 887.60 | 371 / 803 | 0% | 0 | 0 / 0 |
brain | 13% | 175.29 | 341 / 2642 | 26% | 9.32 | 185 / 705 |
eye | 0% | 0 | 0 / 0 | 31% | 8.15 | 25 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1901222 | Biological process | regulation of non-canonical NF-kappaB signal transduction |
GO_0070233 | Biological process | negative regulation of T cell apoptotic process |
GO_0046426 | Biological process | negative regulation of receptor signaling pathway via JAK-STAT |
GO_0002467 | Biological process | germinal center formation |
GO_0042832 | Biological process | defense response to protozoan |
GO_0010225 | Biological process | response to UV-C |
GO_0007249 | Biological process | canonical NF-kappaB signal transduction |
GO_0009615 | Biological process | response to virus |
GO_0002268 | Biological process | follicular dendritic cell differentiation |
GO_0006974 | Biological process | DNA damage response |
GO_0042771 | Biological process | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator |
GO_0030198 | Biological process | extracellular matrix organization |
GO_0032733 | Biological process | positive regulation of interleukin-10 production |
GO_0032088 | Biological process | negative regulation of NF-kappaB transcription factor activity |
GO_0070231 | Biological process | T cell apoptotic process |
GO_0045064 | Biological process | T-helper 2 cell differentiation |
GO_0051101 | Biological process | regulation of DNA binding |
GO_0048536 | Biological process | spleen development |
GO_0002315 | Biological process | marginal zone B cell differentiation |
GO_0019730 | Biological process | antimicrobial humoral response |
GO_0030330 | Biological process | DNA damage response, signal transduction by p53 class mediator |
GO_0042981 | Biological process | regulation of apoptotic process |
GO_0042088 | Biological process | T-helper 1 type immune response |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0006606 | Biological process | protein import into nucleus |
GO_0032717 | Biological process | negative regulation of interleukin-8 production |
GO_0042742 | Biological process | defense response to bacterium |
GO_0045727 | Biological process | positive regulation of translation |
GO_0032729 | Biological process | positive regulation of type II interferon production |
GO_0032720 | Biological process | negative regulation of tumor necrosis factor production |
GO_0002455 | Biological process | humoral immune response mediated by circulating immunoglobulin |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0030496 | Cellular component | midbody |
GO_0032996 | Cellular component | Bcl3-Bcl10 complex |
GO_0005886 | Cellular component | plasma membrane |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0033257 | Cellular component | Bcl3/NF-kappaB2 complex |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0005634 | Cellular component | nucleus |
GO_0140297 | Molecular function | DNA-binding transcription factor binding |
GO_0003714 | Molecular function | transcription corepressor activity |
GO_0030674 | Molecular function | protein-macromolecule adaptor activity |
GO_0003713 | Molecular function | transcription coactivator activity |
GO_0005515 | Molecular function | protein binding |
GO_0042826 | Molecular function | histone deacetylase binding |
Gene name | BCL3 |
Protein name | BCL3 transcription coactivator B-cell lymphoma 3 protein (BCL-3) (Proto-oncogene BCL3) |
Synonyms | D19S37 BCL4 |
Description | FUNCTION: Contributes to the regulation of transcriptional activation of NF-kappa-B target genes. In the cytoplasm, inhibits the nuclear translocation of the NF-kappa-B p50 subunit. In the nucleus, acts as transcriptional activator that promotes transcription of NF-kappa-B target genes. Contributes to the regulation of cell proliferation (By similarity). . |
Accessions | P20749 ENST00000164227.10 ENST00000444487.1 H7C0A2 |